Jeff Yass’s Elicio Therapeutics ELTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$99.2K Buy
+54,486
New +$151K ﹤0.01% 12563
2026
Q2
– Sell
-70,804
Closed -$711K – 13652
2026
Q1
$757K Buy
70,804
+6,752
+11% +$65.2K ﹤0.01% 8615
2025
Q4
$510K Sell
64,052
-56,155
-47% -$510K ﹤0.01% 8741
2025
Q3
$1.32M Buy
120,207
+103,184
+606% +$1.04M ﹤0.01% 6681
2025
Q2
$131K Sell
17,023
-14,338
-46% -$89.2K ﹤0.01% 11603
2025
Q1
$193K Buy
+31,361
New +$243K ﹤0.01% 10967
2022
Q4
– Sell
-1,366
Closed -$13K – 12713
2022
Q3
$13K Sell
1,366
-568
-29% -$5.94K ﹤0.01% 12731
2022
Q2
$22K Buy
+1,934
New +$30.9K ﹤0.01% 12339

Other funds holding ELTX

Jeff Yass's ELTX Position: Q3 2026 in Review

Jeff Yass opened a new position in Elicio Therapeutics (ELTX) in Q3 2026: 54,486 shares worth $99.2K. The stake represents ﹤0.01% of the portfolio and ranks #12563 among its holdings. This is a return to the name: Jeff Yass previously reported a position in ELTX as recently as Q1 2026.

Jeff Yass first reported a position in ELTX in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.32M in Q3 2025. 80 funds tracked by Wall St. Rank hold ELTX as of Q3 2026.

  • Jeff Yass held 54,486 shares of Elicio Therapeutics worth $99.2K as of Q3 2026.
  • Elicio Therapeutics was a new Jeff Yass position in Q3 2026.
  • Elicio Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12563 holding.
  • Jeff Yass first reported a position in Elicio Therapeutics in Q2 2022 and has held it in 8 quarters since.
  • Jeff Yass's Elicio Therapeutics position peaked at $1.32M in Q3 2025.
  • 80 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.